Ingersoll Rand Inc.
Financials
Valuation Metrics
Ingersoll Rand Inc.'s Market Cap is $32.39B. At end of 2025 it was $31.13B. Ranked #439 of 3,118 in US market (top 14%), #310 of 1,644 on NYSE (top 19%), #39 of 239 in Capital Goods (top 16%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $32.39B | US#439/3,118 Sec#39/239 |
| Revenue | $7.94B | US#650/3,118 Sec#56/239 |
| Net Income | $959M | US#557/3,118 Sec#39/239 |
| Total Assets | $18.19B | US#653/3,118 Sec#29/239 |
| Net Assets | $10.18B | US#417/3,118 Sec#22/239 |
| Employees | 21,000 | US#533/3,118 Sec#55/239 |
| Value | ||
| P/E | 33.78x | US#1,648/3,118 Sec#127/239 |
| P/B | 3.18x | US#1,812/3,118 Sec#108/239 |
| PEG | 0.40x | US#512/3,118 Sec#38/239 |
| P/S | 4.08x | US#2,063/3,118 Sec#179/239 |
| EV/EBITDA | 18.29x | US#1,768/3,118 Sec#127/239 |
| FCF Yield | 3.76% | US#1,618/3,118 Sec#106/239 |
| Profitability | ||
| ROE | 9.42% | US#1,420/3,118 Sec#141/239 |
| ROA | 5.27% | US#999/3,118 Sec#117/239 |
| Op. Margin | 21.52% | US#816/3,118 Sec#22/239 |
| Revenue Growth | 7.85% | US#1,458/3,118 Sec#137/239 |
| Earnings Growth | 83.52% | US#341/3,118 Sec#33/239 |
| Financial Health | ||
| Debt Ratio | 78.13% | US#872/3,118 Sec#61/239 |
| Total Debt | $4.83B | US#692/3,118 Sec#34/239 |
| FCF | $1.22B | US#506/3,118 Sec#35/239 |
| Cash | $1.17B | US#603/3,118 Sec#38/239 |
| Current Ratio | 1.62x | US#1,527/3,118 Sec#155/239 |
| Net Debt/EBITDA | 1.86x | US#1,283/3,118 Sec#114/239 |
| Dividend | ||
| Div. Yield | 0.10% | US#1,688/3,118 Sec#153/239 |
| Div. Growth | -0.25% | US—/3,118 Sec—/239 |
| Performance | ||
| 1Y Return | 8.50% | US#1,761/3,118 Sec#121/239 |
| 1M Return | 8.82% | US#1,094/3,118 Sec#65/239 |
| From 52W High | -17.99% | US#1,511/3,118 Sec#81/239 |
| 1Y MDD | -30.58% | US#1,352/3,118 Sec#92/239 |
| Trading | ||
| Volume | 4,053,887 shares | US#382/3,118 Sec#19/239 |
| Trading Value | $335M | US#285/3,118 Sec#27/239 |
| Per Share | ||
| EPS | $2.45 | US#1,198/3,118 Sec#124/239 |
| BPS | $26.01 | US#1,009/3,118 Sec#105/239 |
Company Info
Ingersoll Rand Inc. provides various mission-critical air, fluid, clean energy, and medical technologies services and solutions worldwide. It operates in two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services a range of air and gas compression and treatment equipment, vacuum, and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment; and other specialized equipment, including associated aftermarket parts, consumables and services, air treatment equipment, controls, other accessories, and services under the Ingersoll Rand, Gardner Denver, Nash, CompAir, Elmo Rietschle, and other brands. The Precision and Science Technologies segment designs, manufactures, and markets diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps; and gas boosters, hydrogen compression systems, automated liquid handling systems, odorant injection systems, controls, software, and other related components and accessories for precision dosing, liquid and solid transfer, dispensing, gas compression and sampling, pressure management, flow control, powder handling, and other applications under the Air Dimensions, Albin, ARO, Dosatron, Haskel, Ingersoll Rand, LMI, Maximus, Milton Roy, MP, Oberdorfer, Seepex, Thomas, Welch, Williams, YZ, and Zinnser Analytic brands. This segment's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. It sells its products through an integrated network of direct sales representatives and independent distributors. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.